This is the authors' abstract. We don't add key points for this paper.
経口免疫療法(oral immunotherapy:OIT)は食物アレルギー児における脱感作や持続的無反応を期待できるが,安全性,有効性,治療継続性に課題が残る.本稿では日本と海外のOITの対象選択や実施方法の違いを中心に概説する.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Nagakura et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: